Global Molecular Diagnostics Market (2016-2022) - Growing Adoption of Personalized Medicines & Companion Diagnostics - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Molecular Diagnostics Market (2016-2022)" report to their offering.

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

The key driving factors for molecular diagnostics market are high prevalence of infectious diseases and adoption of personalized medicines & companion diagnostics. Additionally, advanced diagnostics technologies and increase in the number of cancer diagnostics are some of the other factors leading the market growth. However, high cost of molecular equipment and delay in the approval of new molecular diagnostics tests could restraint growth of molecular diagnostic market.

North America is expected to dominate the market growth owing to the increase in the number of infectious diseases. Unhealthy lifestyle and infectious diseases are becoming the major concerns worldwide. According to the data estimated by Centers for Diseases Control and Prevention (CDC), the estimated number of deaths due to cancer was 591,699 and chronic lower respiratory diseases was 147,101. Additionally, according to the statistics in 2016, approximately 5.1 million people are living with HIV in Asian regions. In 2015, there were an estimated 300,000 new infections in the Asia-Pacific region. Hence, it could be expected that Asia Pacific and other regions would be contributing in the growth of molecular diagnostics market.

Companies Mentioned

  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation

Key Topics Covered:

1. Market Scope & Methodology

2. Executive Summary

3. Market Overview

4. North America Molecular Diagnostics Market

5. North America Molecular Diagnostics Market by Technology

6. North America Molecular Diagnostics Market by Application

7. North America Molecular Diagnostics Market by End User

8. North America Molecular Diagnostics Market by Country

9. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/zvv6gx/global_molecular

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics, Molecular Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: In Vitro Diagnostics, Molecular Diagnostics